Geoffrey Duyk is the founder of Grove Biopharma. Grove Biopharma has raised $30M in total funding. Latest round: Series A. Based in Chicago, United States.
Geoffrey Duyk is the Co-founder and CEO of Grove Biopharma, a private biotechnology company based in San Mateo, California. The company is developing therapies targeting previously intractable intracellular disease targets using its Bionic Biologics platform. Grove Biopharma recently closed a $30 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library